Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01523184 · ClinicalTrials.gov registry record · Phase 2
A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation
A Phase 2 study, sponsored by SK Life Science.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
NCT01523184 is a Phase 2 study that has completed, run by SK Life Science. The registered enrollment target is 57 participants.
The verdict
NCT01523184, a Phase 2 study, has completed, sponsored by SK Life Science.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
Study Summary
This will be a single-center, randomized, parallel group, multiple dose administration, double-blind, placebo-controlled study to evaluate the effects of YKP10811 on gastric, small bowel, and colonic transit in patients with Chronic Constipation or Functional Constipation. Four groups including a placebo group will be enrolled and will receive multiple oral doses of YKP10811 or matching placebo.
Interventions
- DRUG Placebo Capsule
- DRUG YKP10811 Drug Product Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01523184
The ClinicalTrials.gov registry entry for NCT01523184 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SK Life Science, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Capsule is the first listed.
NCT01523184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01523184 about?
NCT01523184 is a clinical study titled "A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation". This will be a single-center, randomized, parallel group, multiple dose administration, double-blind, placebo-controlled study to evaluate the effects of YKP10811 on gastric, small bowel, and colonic transit in patients with Chronic Constipation or Functional Constipation. Four groups including a pl...
What is the current status of trial NCT01523184?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2012-03. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01523184?
The interventions under investigation include: Placebo Capsule (DRUG), YKP10811 Drug Product Capsule (DRUG).
Who is sponsoring clinical trial NCT01523184?
This trial is sponsored by SK Life Science, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.